A Trial of C13-CAC Breath Test in PPI Resistant GERD Patients

NCT03284177 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

55

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastroesophageal Reflux Disease

Interventions

DRUG: Calcium (13C)Carbonate
DRUG: Gastric acid inhibitors
OTHER: Gastric pH monitoring

Sponsor

Otsuka Pharmaceutical Co., Ltd.